Detalhe da pesquisa
1.
The aged tumor microenvironment limits T cell control of cancer.
Nat Immunol
; 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38745085
2.
Not-so-opposite ends of the spectrum: CD8+ T cell dysfunction across chronic infection, cancer and autoimmunity.
Nat Immunol
; 22(7): 809-819, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34140679
3.
Epigenetic scars of CD8+ T cell exhaustion persist after cure of chronic infection in humans.
Nat Immunol
; 22(8): 1020-1029, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34312547
4.
Author Correction: Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade.
Nat Immunol
; 20(11): 1556, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31582823
5.
Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade.
Nat Immunol
; 20(3): 326-336, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30778252
6.
Publisher Correction: Gene regulation: c-Maf in CD4+ T cells: it's all about context.
Nat Immunol
; 19(10): 1146, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30143753
7.
c-Maf in CD4+ T cells: it's all about context.
Nat Immunol
; 19(5): 429-431, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29670237
8.
A bedside to bench study of anti-PD-1, anti-CD40, and anti-CSF1R indicates that more is not necessarily better.
Mol Cancer
; 22(1): 182, 2023 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37964379
9.
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target.
Nature
; 547(7664): 413-418, 2017 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28723893
10.
Melanoma brain metastases have lower T-cell content and microvessel density compared to matched extracranial metastases.
J Neurooncol
; 152(1): 15-25, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32974852
11.
Incidence and characteristics of metastatic intracranial lesions in stage III and IV melanoma: a single institute retrospective analysis.
J Neurooncol
; 154(2): 197-203, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34351544
12.
PLEKHA5 regulates tumor growth in metastatic melanoma.
Cancer
; 126(5): 1016-1030, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31769872
13.
Treatment Outcomes for Metastatic Melanoma of Unknown Primary in the New Era: A Single-Institution Study and Review of the Literature.
Oncology
; 93(4): 249-258, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28746931
14.
Impact of aging on host immune response and survival in melanoma: an analysis of 3 patient cohorts.
J Transl Med
; 14(1): 299, 2016 10 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27760559
15.
Correction to: Incidence and characteristics of metastatic intracranial lesions in stage III and IV melanoma: a single institute retrospective analysis.
J Neurooncol
; 154(2): 205, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34403041
16.
Revisiting determinants of prognosis in cutaneous melanoma.
Cancer
; 121(23): 4108-23, 2015 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26308244
17.
Update on vaccines for high-risk melanoma.
Curr Treat Options Oncol
; 15(2): 269-80, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24788575
18.
A Phase II Trial of the CD40 Agonistic Antibody Sotigalimab (APX005M) in Combination with Nivolumab in Subjects with Metastatic Melanoma with Confirmed Disease Progression on Anti-PD-1 Therapy.
Clin Cancer Res
; 30(1): 74-81, 2024 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37535056
19.
Lenvatinib or anti-VEGF in combination with anti-PD-1 differentially augments antitumor activity in melanoma.
JCI Insight
; 8(7)2023 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36821392
20.
The role of imaging and sentinel lymph node biopsy in patients with T3b-T4b melanoma with clinically negative disease.
Front Oncol
; 13: 1143354, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37223678